Abstract:Guocan Yu, 1 Yanqin Shen, 2 Liwei Yao, 2 Xudong Xu 1 1 Zhejiang Tuberculosis Diagnosis and Treatment Center, Hangzhou Red Cross Hospital, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China; 2 Department of Nursing, Hangzhou Red Cross Hospital, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China Correspondence: Liwei Yao; Xudong Xu, Email ; Purpose: This study aimed to evaluate the efficacy of nanopore sequencing for diagnosing pulmonary tuberculosis (PTB) using smear-negative clinical specimens. Methods: We conducted a retrospective study based on a review of patient medical records to assess the accuracy of nanopore sequencing as a diagnostic tool for smear-negative PTB. Compared with clinical diagnosis, we determined the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) of nanopore sequencing. Results: A total of 647 patients were evaluated. Nanopore sequencing demonstrated an overall sensitivity of 91.7%, specificity of 85.3%, PPV of 95.1%, NPV of 76.4%, and AUC of 0.88. Notably, the overall diagnostic accuracy of nanopore sequencing was significantly higher than that of Mycobacterium tuberculosis (MTB) culture technique. Conclusion: Nanopore sequencing exhibited satisfactory overall diagnostic accuracy for smear-negative PTB, regardless of MTB culture status. Therefore, if conditions permit, nanopore sequencing is recommended as a diagnostic method for smear-negative PTB. Keywords: nanopore sequencing, smear-negative specimens, pulmonary tuberculosis, diagnostic accuracy Tuberculosis (TB) is a highly contagious disease caused by Mycobacterium tuberculosis (MTB), which continues to pose threats in the field of global health, as indicated by recent statistical data. 1 In 2022, 10.6 million new TB diagnoses and 1.3 million TB deaths were recorded worldwide. 1 Consequently, TB ranked among the top 10 causes of death attributed to a single infectious disease. 2 The most prevalent form of TB is pulmonary TB (PTB), accounting for approximately 70–85% of all TB cases. 3 PTB serves as the primary source of TB transmission. 4 Therefore, controlling the source of infection is crucial for reducing the spread of TB. Effective detection and treatment of PTB are key for controlling the source of infection effectively. Acid-fast bacilli (AFB) smear is the most widely used clinical method for diagnosing PTB. 5 However, it exhibits low sensitivity, indicating that a large proportion of patients present with a negative AFB smear. 6 Smear-negative PTB cases are easily overlooked, resulting in PTB transmission. 2 Improving the diagnostic accuracy of PTB using smear-negative clinical specimens remains a major challenge. Although MTB culture technique is essential for PTB diagnosis, it requires a long time and cannot facilitate early diagnosis. 7 Moreover, smear-negative PTB specimens may exhibit lower MTB content than smear-positive PTB specimens, resulting in a reduced culture positivity rate. 8 Consequently, relying solely on MTB culture technique for diagnosing smear-negative PTB may have limited efficacy. 9 The development of molecular diagnostic techniques in recent years has led to significant advancements in the rapid diagnosis of infectious diseases, including TB. 10,11 Xpert MTB/RIF is the most widely used molecular test for rapid diagnosis of TB recommended by the World Health Organization, also in China. 12 However, its accuracy in paucibacillary TB diagnosis still needs to be further improved. 13 Genetic sequencing is widely used in the field of infectious diseases and offers unique advantages for the rapid diagnosis of TB. 13,14 The utilization of next-generation sequencing (NGS) in TB has demonstrated remarkable diagnostic efficacy, thereby greatly improving TB diagnosis. 15 Nanopore sequencing is a unique and scalable technology that monitors changes in the current of nucleic acids as they pass through nanopore proteins. The resulting signal is decoded to provide specific DNA or RNA sequences. 16 Nanopore sequencing offers portability, real-time analysis, and long read lengths compared with other NGS techniques. 17,18 Its ability to directly detect and decode genetic material with high accuracy and efficiency will undoubtedly revolutionize various fields of research and significantly contribute to advancements in personalized medicine and molecular biology. I -Abstract Truncated-

Evaluation of Mycobacterium tuberculosis enrichment in metagenomic samples using ONT adaptive sequencing and amplicon sequencing for identification and variant calling

Exploring the potential of Oxford Nanopore Technologies sequencing for Mycobacterium tuberculosis sequencing: An assessment of R10 flowcells and V14 chemistry

Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples

Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologies

Multi-platform whole genome sequencing for tuberculosis clinical and surveillance applications

Enrichment of long DNA fragments from mixed samples for Nanopore sequencing

Targeted sequencing of Enterobacterales bacteria using CRISPR-Cas9 enrichment and Oxford Nanopore Technologies

Diagnostic Accuracy of Nanopore Sequencing for Detecting Mycobacterium tuberculosis and Drug-Resistant Strains: A Systematic Review and Meta-Analysis

Accurate genotyping of three major respiratory bacterial pathogens with ONT R10.4.1 long-read sequencing

An ultra-sensitive bacterial pathogens and antimicrobial resistance diagnosis workflow using Oxford Nanopore adaptive sampling sequencing method

Nanopore-based targeted next-generation sequencing of tissue samples for tuberculosis diagnosis

Evaluation of Nanopore Sequencing for Diagnosing Pulmonary Tuberculosis Using Negative Smear Clinical Specimens

High-throughput nanopore targeted sequencing for efficient drug resistance assay of Mycobacterium tuberculosis

Clinical utility of target amplicon sequencing test for rapid diagnosis of drug-resistant Mycobacterium tuberculosis from respiratory specimens

Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study

A preliminary evaluation of targeted nanopore sequencing technology for the detection of Mycobacterium tuberculosis in bronchoalveolar lavage fluid specimens

A rapid bacterial pathogen and antimicrobial resistance diagnosis workflow using Oxford nanopore adaptive sequencing method

An evolution of Nanopore next-generation sequencing technology: implications for medical microbiology and public health

A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing

Closing the gap: Oxford Nanopore Technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens

Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsis